Biotechnology
Medical
Biopharmaceutical
Regeneron
$299.429876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$299.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.05 (0.35%) Today
$0.00 (0.00%) As of 5:53 PM EDT after-hours
Why Robinhood?
You can buy or sell Regeneron and other stocks, options, ETFs, and crypto commission-free!
About REGN
Regeneron Pharmaceuticals, Inc. Common Stock, also called Regeneron, is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Read More It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.
Employees
7,400
Headquarters
Tarrytown, New York
Founded
1988
Market Cap
32.70B
Price-Earnings Ratio
14.12
Dividend Yield
0.00
Average Volume
892.03K
High Today
$303.30
Low Today
$297.08
Open Price
$297.26
Volume
646.32K
52 Week High
$442.00
52 Week Low
$287.66
Collections
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
Technology
REGN News
Price Paid on Robinhood
21% Lower
Right Now
52 Week Low
$281.89
Average Price Paid
$379.27
52 Week High
$442.00
Analyst Ratings
33%
of 24 ratings
Buy
33%
Hold
63%
Sell
4%
REGN Earnings
$4.32
$5.16
$6.00
$6.84
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Available Aug 6, Pre-Market